Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSMUSG00000021400.6 | Werner helicase interacting protein 1 |
Mta3
|
ENSMUSG00000055817.11 | metastasis associated 3 |
Rcor1
|
ENSMUSG00000037896.11 | REST corepressor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_83732225_83732442 | Mta3 | 3169 | 0.313153 | -0.72 | 4.5e-10 | Click! |
chr17_83736835_83737028 | Mta3 | 7767 | 0.248139 | -0.71 | 1.9e-09 | Click! |
chr17_83782847_83783018 | Mta3 | 5989 | 0.228565 | 0.63 | 2.5e-07 | Click! |
chr17_83809218_83809497 | Mta3 | 13935 | 0.175092 | -0.62 | 4.9e-07 | Click! |
chr17_83737953_83738112 | Mta3 | 8868 | 0.243453 | -0.62 | 5.3e-07 | Click! |
chr12_111035288_111035460 | Rcor1 | 3977 | 0.150093 | -0.70 | 2.0e-09 | Click! |
chr12_111029317_111029547 | Rcor1 | 9919 | 0.119631 | -0.62 | 3.9e-07 | Click! |
chr12_111028899_111029063 | Rcor1 | 10370 | 0.118638 | -0.61 | 8.9e-07 | Click! |
chr12_111029590_111029751 | Rcor1 | 9681 | 0.120171 | -0.59 | 2.0e-06 | Click! |
chr12_111035545_111035743 | Rcor1 | 3707 | 0.154546 | -0.51 | 6.1e-05 | Click! |
chr13_32827235_32827386 | Wrnip1 | 6544 | 0.142094 | -0.51 | 7.5e-05 | Click! |
chr13_32824386_32824668 | Wrnip1 | 3761 | 0.166760 | -0.49 | 1.3e-04 | Click! |
chr13_32801530_32801709 | Wrnip1 | 419 | 0.715979 | 0.36 | 7.6e-03 | Click! |
chr13_32801775_32802733 | Wrnip1 | 138 | 0.855709 | 0.31 | 2.3e-02 | Click! |
chr13_32828072_32828223 | Wrnip1 | 7381 | 0.138954 | -0.19 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_81559146_81561402 | 147.38 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr12_3236518_3237725 | 137.55 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr19_61225302_61226760 | 131.55 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr2_33130296_33131698 | 115.74 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr7_44310178_44311500 | 96.01 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr10_81429712_81431957 | 85.31 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr1_3671269_3672324 | 85.17 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr2_165511107_165511805 | 80.75 |
Slc2a10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
2675 |
0.23 |
chr9_86879639_86880662 | 80.17 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr9_124439906_124440949 | 79.08 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr12_112721309_112722969 | 78.93 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr8_12873206_12874084 | 75.43 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr19_36553934_36555231 | 75.17 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr7_84409236_84410328 | 73.85 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr8_4212633_4214018 | 73.40 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr12_111758304_111760062 | 69.69 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr16_44687184_44688343 | 68.62 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr2_94273064_94274137 | 68.33 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr2_102451171_102452295 | 67.26 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr7_16129395_16130325 | 67.15 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
34 |
0.96 |
chr2_17730264_17731671 | 66.85 |
Nebl |
nebulette |
76 |
0.98 |
chr9_72924923_72926161 | 66.76 |
Pygo1 |
pygopus 1 |
103 |
0.93 |
chr2_73385763_73387080 | 65.24 |
Gpr155 |
G protein-coupled receptor 155 |
9 |
0.9 |
chr8_125569269_125570645 | 64.27 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr16_16561093_16561486 | 62.84 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr2_127521161_127522051 | 61.22 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr17_13759899_13761731 | 60.84 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr8_70476397_70477967 | 60.71 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr3_134339308_134339650 | 60.61 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr14_34819764_34820558 | 60.34 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
53 |
0.98 |
chr5_24482511_24483721 | 59.50 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2944 |
0.12 |
chr2_132029196_132030408 | 59.11 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr19_10041145_10042475 | 57.03 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr3_100550980_100551317 | 56.95 |
Gm43466 |
predicted gene 43466 |
36379 |
0.11 |
chr11_22858998_22860305 | 56.76 |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
106 |
0.89 |
chr7_19094759_19096427 | 56.49 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr17_8800581_8801529 | 56.24 |
Pde10a |
phosphodiesterase 10A |
638 |
0.79 |
chrX_13346707_13347908 | 56.21 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr14_14345884_14346978 | 56.20 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr13_48966851_48968700 | 55.48 |
Fam120a |
family with sequence similarity 120, member A |
242 |
0.95 |
chr6_127768794_127769871 | 55.11 |
Prmt8 |
protein arginine N-methyltransferase 8 |
140 |
0.91 |
chr3_34649198_34650117 | 55.08 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr2_126932364_126933545 | 54.90 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr2_77816275_77817277 | 54.84 |
Zfp385b |
zinc finger protein 385B |
40 |
0.98 |
chr11_4572974_4574056 | 54.60 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr4_152273539_152274471 | 54.40 |
Gpr153 |
G protein-coupled receptor 153 |
227 |
0.89 |
chr5_38158989_38159808 | 54.02 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr2_173658978_173659962 | 54.01 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr14_6037512_6038662 | 53.93 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr9_13246797_13247848 | 53.93 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr10_83722468_83723424 | 53.84 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr19_38054215_38055320 | 53.71 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr7_24883912_24885132 | 53.51 |
Rps19 |
ribosomal protein S19 |
111 |
0.92 |
chr2_151701768_151703133 | 53.37 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr14_3948585_3949537 | 53.01 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr1_132880253_132881745 | 52.89 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
644 |
0.72 |
chr8_4206127_4207837 | 52.25 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr17_52601056_52601789 | 51.98 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr12_108333504_108334768 | 51.78 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr12_3364588_3366025 | 51.57 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr14_4018192_4019443 | 51.40 |
Gm5796 |
predicted gene 5796 |
5124 |
0.14 |
chr7_4119309_4120004 | 50.94 |
Ttyh1 |
tweety family member 1 |
34 |
0.91 |
chr13_18947816_18948472 | 50.61 |
Amph |
amphiphysin |
61 |
0.97 |
chr16_28445903_28447087 | 50.48 |
Fgf12 |
fibroblast growth factor 12 |
218 |
0.97 |
chr18_77564959_77566098 | 50.47 |
Rnf165 |
ring finger protein 165 |
367 |
0.89 |
chr5_150593023_150594879 | 49.78 |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
182 |
0.88 |
chr17_66448520_66450314 | 49.70 |
Mtcl1 |
microtubule crosslinking factor 1 |
333 |
0.57 |
chr14_4110111_4111235 | 49.61 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr6_124915577_124916697 | 49.61 |
Ptms |
parathymosin |
608 |
0.37 |
chr9_62536098_62537614 | 49.55 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr18_25678986_25679896 | 49.54 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
34329 |
0.19 |
chr10_81464661_81465630 | 48.83 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr2_93187957_93189155 | 48.58 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr4_20777672_20778960 | 48.38 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr4_101068780_101069771 | 47.70 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
204 |
0.93 |
chr5_142701305_142702538 | 47.62 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
180 |
0.95 |
chr14_14350947_14351733 | 47.56 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr11_80080470_80081713 | 47.44 |
Crlf3 |
cytokine receptor-like factor 3 |
100 |
0.96 |
chr14_7244047_7245236 | 47.34 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr1_74284190_74285456 | 47.32 |
Aamp |
angio-associated migratory protein |
85 |
0.51 |
chr5_71095688_71096242 | 47.30 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
116 |
0.98 |
chr3_88205532_88206477 | 47.15 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr9_8900765_8902148 | 47.12 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr2_105674521_105675719 | 47.10 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr8_9771269_9772260 | 47.09 |
Fam155a |
family with sequence similarity 155, member A |
603 |
0.53 |
chr7_34570196_34571084 | 47.06 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr9_20726843_20728134 | 46.97 |
Olfm2 |
olfactomedin 2 |
551 |
0.72 |
chr17_13654565_13655321 | 46.91 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr11_98959522_98960759 | 46.86 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr10_77417184_77418713 | 46.81 |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
94 |
0.97 |
chr17_45548642_45549512 | 46.79 |
Tmem151b |
transmembrane protein 151B |
600 |
0.55 |
chr1_93176328_93177269 | 46.55 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
8073 |
0.13 |
chr17_52602043_52602770 | 46.53 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chr16_44632721_44633371 | 46.53 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr7_4995595_4996371 | 46.49 |
Zfp579 |
zinc finger protein 579 |
46 |
0.92 |
chr8_71670876_71671939 | 46.41 |
Unc13a |
unc-13 homolog A |
329 |
0.75 |
chr12_105336634_105337535 | 46.41 |
Tunar |
Tcl1 upstream neural differentiation associated RNA |
91 |
0.97 |
chr14_14349938_14350878 | 46.23 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr19_42431698_42432696 | 46.21 |
Crtac1 |
cartilage acidic protein 1 |
412 |
0.84 |
chr6_55451539_55452374 | 46.10 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr10_81364518_81366962 | 46.09 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr18_12643212_12644484 | 46.04 |
Ttc39c |
tetratricopeptide repeat domain 39C |
486 |
0.46 |
chr14_3208167_3209194 | 45.97 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr8_70315603_70316677 | 45.89 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chrX_81070276_81071390 | 45.64 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr7_57590461_57591180 | 45.62 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
302 |
0.92 |
chr14_7314343_7315443 | 45.62 |
Gm3739 |
predicted gene 3739 |
156 |
0.94 |
chr12_67221407_67222428 | 45.24 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
464 |
0.88 |
chr15_40654880_40655719 | 45.24 |
Zfpm2 |
zinc finger protein, multitype 2 |
52 |
0.99 |
chr9_75625075_75626579 | 45.11 |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
68 |
0.96 |
chr3_55242068_55243398 | 45.11 |
Dclk1 |
doublecortin-like kinase 1 |
207 |
0.94 |
chr15_75566838_75567525 | 45.04 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
35 |
0.96 |
chr1_54925534_54926512 | 44.85 |
Ankrd44 |
ankyrin repeat domain 44 |
331 |
0.88 |
chr10_89872924_89873647 | 44.80 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
224 |
0.95 |
chr3_63295219_63296243 | 44.77 |
Mme |
membrane metallo endopeptidase |
141 |
0.98 |
chr14_66910808_66911486 | 44.70 |
Pnma2 |
paraneoplastic antigen MA2 |
23 |
0.97 |
chr8_4492910_4494136 | 44.69 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr1_89069533_89070748 | 44.54 |
Sh3bp4 |
SH3-domain binding protein 4 |
275 |
0.91 |
chr5_65106807_65107827 | 44.54 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr13_34129793_34130880 | 44.42 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr6_87980723_87981994 | 43.95 |
H1f10 |
H1.10 linker histone |
279 |
0.39 |
chr7_31127074_31128340 | 43.89 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr1_14755119_14756069 | 43.87 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr7_63444022_63445137 | 43.85 |
4930554H23Rik |
RIKEN cDNA 4930554H23 gene |
50 |
0.67 |
chr14_4726126_4727100 | 43.67 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr3_108085301_108086522 | 43.61 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr9_106452968_106454846 | 43.56 |
Pcbp4 |
poly(rC) binding protein 4 |
8 |
0.92 |
chr15_25754647_25755340 | 43.56 |
Myo10 |
myosin X |
2014 |
0.38 |
chr1_92831123_92832495 | 43.53 |
Gpc1 |
glypican 1 |
160 |
0.92 |
chr5_23675895_23676511 | 43.50 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr6_121473518_121474161 | 43.41 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
161 |
0.96 |
chr6_136173009_136173858 | 43.33 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
56 |
0.85 |
chr2_157464727_157465479 | 43.33 |
Src |
Rous sarcoma oncogene |
8018 |
0.18 |
chr16_23224637_23225757 | 43.16 |
BC106179 |
cDNA sequence BC106179 |
171 |
0.76 |
chr15_25364173_25365245 | 43.13 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
32050 |
0.14 |
chr17_13590938_13591623 | 43.12 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr5_121836427_121837736 | 43.02 |
Sh2b3 |
SH2B adaptor protein 3 |
222 |
0.86 |
chr13_99516425_99517155 | 43.00 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr6_120294093_120295041 | 42.86 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
8 |
0.98 |
chr8_4216526_4217378 | 42.77 |
Prr36 |
proline rich 36 |
40 |
0.94 |
chr10_90828740_90829725 | 42.71 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
111 |
0.96 |
chr2_30718241_30719386 | 42.69 |
Gm14488 |
predicted gene 14488 |
1244 |
0.36 |
chr7_79535477_79536145 | 42.63 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr2_139677053_139678960 | 42.58 |
Ism1 |
isthmin 1, angiogenesis inhibitor |
172 |
0.66 |
chr8_122284023_122284944 | 42.45 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr14_3332417_3333262 | 42.23 |
Gm2956 |
predicted gene 2956 |
212 |
0.91 |
chr10_79613505_79614566 | 42.21 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr14_14347096_14348750 | 42.15 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr16_90283526_90284553 | 42.10 |
Scaf4 |
SR-related CTD-associated factor 4 |
269 |
0.9 |
chr2_65022121_65023287 | 41.92 |
Grb14 |
growth factor receptor bound protein 14 |
78 |
0.98 |
chr7_43490136_43490673 | 41.85 |
Iglon5 |
IgLON family member 5 |
329 |
0.72 |
chr13_92425671_92426978 | 41.84 |
Ankrd34b |
ankyrin repeat domain 34B |
17 |
0.95 |
chr15_74563715_74564797 | 41.69 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
355 |
0.54 |
chr2_153031457_153032069 | 41.67 |
Xkr7 |
X-linked Kx blood group related 7 |
89 |
0.95 |
chr4_138325465_138326730 | 41.54 |
Gm27646 |
predicted gene, 27646 |
8 |
0.64 |
chr18_74064418_74065509 | 41.48 |
Mapk4 |
mitogen-activated protein kinase 4 |
34 |
0.63 |
chr14_4334095_4335404 | 41.46 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
14 |
0.97 |
chr11_6599159_6600158 | 41.45 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr5_8622107_8622828 | 41.35 |
Rundc3b |
RUN domain containing 3B |
485 |
0.81 |
chr11_47988672_47989535 | 41.32 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
134 |
0.98 |
chr15_103339347_103340247 | 41.31 |
Zfp385a |
zinc finger protein 385A |
296 |
0.82 |
chr16_46009777_46011157 | 41.19 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr10_78747019_78747870 | 41.15 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr2_32606859_32607676 | 41.12 |
St6galnac6 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
224 |
0.83 |
chr13_12650037_12651101 | 41.00 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr12_29871996_29872873 | 40.98 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr1_79858099_79859256 | 40.89 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
19 |
0.98 |
chr3_94477953_94478530 | 40.88 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr1_92847829_92849060 | 40.82 |
Gm29480 |
predicted gene 29480 |
327 |
0.77 |
chr5_33995599_33996957 | 40.68 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr9_106464770_106466154 | 40.64 |
Gpr62 |
G protein-coupled receptor 62 |
476 |
0.6 |
chr17_37049946_37051278 | 40.63 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
19 |
0.95 |
chr9_83806172_83806700 | 40.52 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr10_36506466_36507103 | 40.46 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
30 |
0.99 |
chr1_63445869_63446575 | 40.43 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
11 |
0.98 |
chr8_12915219_12915955 | 40.42 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr14_7567758_7569131 | 40.41 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr12_80518528_80519832 | 40.40 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
190 |
0.58 |
chr8_80738786_80739993 | 40.34 |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
36 |
0.98 |
chr9_45663652_45664379 | 40.30 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr11_54303609_54304215 | 40.30 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr7_29210966_29212124 | 40.26 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
50 |
0.94 |
chr5_37028527_37029187 | 40.21 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr2_3117961_3119194 | 40.20 |
Fam171a1 |
family with sequence similarity 171, member A1 |
108 |
0.97 |
chr9_40268412_40269319 | 40.16 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr14_7488010_7488824 | 40.08 |
Gm3752 |
predicted gene 3752 |
4655 |
0.16 |
chr9_16501284_16502590 | 40.08 |
Fat3 |
FAT atypical cadherin 3 |
652 |
0.82 |
chr9_90269973_90270914 | 40.01 |
Tbc1d2b |
TBC1 domain family, member 2B |
326 |
0.88 |
chr16_33605736_33606716 | 39.96 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr10_125388906_125389759 | 39.84 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
36 |
0.95 |
chr17_35836572_35837313 | 39.83 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr14_5961062_5962084 | 39.75 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr3_73056881_73057482 | 39.72 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr7_109010582_109011352 | 39.72 |
Tub |
tubby bipartite transcription factor |
142 |
0.95 |
chr14_6889264_6890534 | 39.71 |
Gm3667 |
predicted gene 3667 |
63 |
0.97 |
chr15_26308701_26309304 | 39.68 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
46 |
0.99 |
chr9_53705535_53706804 | 39.63 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr4_59548682_59549911 | 39.57 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
1 |
0.64 |
chr13_55487049_55488117 | 39.52 |
Dbn1 |
drebrin 1 |
50 |
0.94 |
chr7_30291145_30292058 | 39.42 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
66.3 | 198.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
50.9 | 203.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
49.5 | 148.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
46.7 | 140.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
46.5 | 232.3 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
45.7 | 137.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
40.3 | 40.3 | GO:0021550 | medulla oblongata development(GO:0021550) |
40.3 | 120.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
36.5 | 72.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
35.7 | 107.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
35.3 | 105.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
35.1 | 281.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
34.8 | 174.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
34.7 | 34.7 | GO:0021557 | oculomotor nerve development(GO:0021557) |
34.6 | 311.5 | GO:0071625 | vocalization behavior(GO:0071625) |
33.1 | 99.2 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
32.7 | 196.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
32.6 | 97.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
32.4 | 97.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
32.3 | 96.9 | GO:0021564 | vagus nerve development(GO:0021564) |
30.9 | 185.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
30.5 | 152.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
30.4 | 91.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
29.9 | 149.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
29.8 | 29.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
29.7 | 148.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
29.6 | 88.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
29.5 | 88.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
29.4 | 147.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
28.6 | 85.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
28.3 | 28.3 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
28.0 | 223.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
27.9 | 83.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
27.8 | 83.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
27.6 | 110.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
27.3 | 81.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
27.1 | 189.6 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
26.8 | 53.7 | GO:0046959 | habituation(GO:0046959) |
26.8 | 134.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
26.5 | 79.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
26.3 | 210.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
26.0 | 78.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
25.5 | 25.5 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
25.0 | 425.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
24.5 | 195.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
24.4 | 73.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
24.2 | 72.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
24.0 | 24.0 | GO:0090135 | actin filament branching(GO:0090135) |
23.9 | 47.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
23.9 | 47.8 | GO:0021586 | pons maturation(GO:0021586) |
23.7 | 71.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
23.7 | 94.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
23.6 | 94.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
23.5 | 47.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
23.5 | 23.5 | GO:0098597 | observational learning(GO:0098597) |
23.3 | 46.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
23.1 | 46.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
23.1 | 92.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
22.7 | 68.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
22.6 | 67.9 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
22.6 | 67.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
22.6 | 67.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
22.3 | 67.0 | GO:0061743 | motor learning(GO:0061743) |
22.1 | 22.1 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
22.0 | 88.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
22.0 | 44.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
21.9 | 43.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
21.8 | 21.8 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
21.8 | 21.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
21.6 | 64.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
21.6 | 108.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
21.5 | 107.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
21.5 | 64.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
21.4 | 85.5 | GO:0030035 | microspike assembly(GO:0030035) |
21.3 | 21.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
21.1 | 169.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
21.1 | 84.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
21.1 | 63.2 | GO:0030070 | insulin processing(GO:0030070) |
21.0 | 62.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
20.9 | 251.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
20.9 | 62.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
20.8 | 104.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
20.8 | 41.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
20.8 | 62.4 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
20.6 | 61.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
20.5 | 81.9 | GO:0090427 | activation of meiosis(GO:0090427) |
20.4 | 102.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
20.3 | 61.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
20.3 | 40.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
20.2 | 40.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
20.2 | 20.2 | GO:0021764 | amygdala development(GO:0021764) |
20.0 | 100.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
20.0 | 39.9 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
19.9 | 59.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
19.8 | 59.4 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
19.6 | 254.7 | GO:0008038 | neuron recognition(GO:0008038) |
19.6 | 97.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
19.6 | 39.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
19.5 | 58.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
19.5 | 39.0 | GO:0060166 | olfactory pit development(GO:0060166) |
19.5 | 58.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
19.3 | 57.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
19.2 | 57.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
19.1 | 306.4 | GO:0001964 | startle response(GO:0001964) |
19.1 | 133.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
19.1 | 38.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
19.0 | 189.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
18.9 | 321.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
18.9 | 56.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
18.7 | 18.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
18.7 | 37.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
18.3 | 128.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
18.2 | 54.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
18.1 | 90.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
18.1 | 380.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
18.0 | 18.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
18.0 | 36.0 | GO:0060594 | mammary gland specification(GO:0060594) |
17.9 | 53.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
17.9 | 53.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
17.8 | 89.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
17.8 | 35.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
17.8 | 53.3 | GO:0001927 | exocyst assembly(GO:0001927) |
17.8 | 53.3 | GO:0097503 | sialylation(GO:0097503) |
17.8 | 88.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
17.7 | 35.5 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
17.7 | 17.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
17.5 | 52.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
17.5 | 17.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
17.3 | 86.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
17.3 | 51.8 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
17.2 | 51.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
17.2 | 189.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
17.1 | 857.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
17.0 | 68.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
17.0 | 51.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
17.0 | 67.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
16.8 | 16.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
16.8 | 50.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
16.7 | 83.6 | GO:0035989 | tendon development(GO:0035989) |
16.6 | 49.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
16.6 | 66.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
16.6 | 33.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
16.6 | 16.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
16.4 | 16.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
16.3 | 114.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
16.3 | 48.8 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
16.2 | 64.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
16.1 | 48.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
16.1 | 144.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
16.0 | 16.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
16.0 | 47.9 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
15.9 | 15.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
15.9 | 111.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
15.8 | 63.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
15.8 | 63.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
15.8 | 31.5 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
15.6 | 15.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
15.6 | 15.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
15.5 | 46.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
15.5 | 62.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
15.5 | 62.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
15.3 | 30.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
15.3 | 76.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
15.2 | 45.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
15.1 | 45.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
14.9 | 209.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
14.9 | 74.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
14.9 | 29.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
14.7 | 44.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
14.7 | 44.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
14.7 | 14.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
14.7 | 88.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
14.7 | 249.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
14.7 | 29.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
14.6 | 14.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
14.5 | 29.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
14.4 | 72.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
14.4 | 14.4 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
14.4 | 100.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
14.3 | 14.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
14.3 | 28.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
14.1 | 28.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
14.0 | 42.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
14.0 | 56.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
14.0 | 41.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
13.9 | 27.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
13.8 | 27.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
13.8 | 110.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
13.7 | 1016.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
13.7 | 13.7 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
13.7 | 54.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
13.7 | 82.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
13.5 | 108.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
13.5 | 27.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
13.5 | 13.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
13.5 | 27.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
13.5 | 255.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
13.5 | 26.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
13.4 | 26.7 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
13.3 | 13.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
13.3 | 13.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
13.2 | 26.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
13.1 | 26.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
13.0 | 52.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
13.0 | 65.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
13.0 | 13.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
13.0 | 13.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
13.0 | 25.9 | GO:0007412 | axon target recognition(GO:0007412) |
13.0 | 64.8 | GO:0048570 | notochord morphogenesis(GO:0048570) |
13.0 | 90.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
12.9 | 25.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
12.8 | 89.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
12.8 | 12.8 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
12.8 | 25.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
12.8 | 12.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
12.8 | 64.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
12.5 | 37.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
12.4 | 37.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
12.4 | 12.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
12.4 | 12.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
12.4 | 37.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
12.3 | 49.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
12.3 | 36.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
12.3 | 36.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
12.3 | 36.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
12.2 | 12.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
12.2 | 61.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
12.2 | 36.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
12.1 | 12.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
12.1 | 121.2 | GO:0060384 | innervation(GO:0060384) |
12.1 | 36.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
12.1 | 12.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
12.1 | 205.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
12.0 | 36.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
12.0 | 36.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
12.0 | 36.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
12.0 | 119.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
11.9 | 23.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
11.9 | 71.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
11.9 | 23.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
11.8 | 106.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
11.7 | 58.6 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
11.7 | 326.8 | GO:0019228 | neuronal action potential(GO:0019228) |
11.7 | 23.3 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
11.6 | 11.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
11.6 | 57.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
11.6 | 11.6 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
11.5 | 11.5 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
11.5 | 11.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
11.4 | 34.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
11.4 | 22.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
11.4 | 45.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
11.4 | 34.1 | GO:0060437 | lung growth(GO:0060437) |
11.3 | 22.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
11.2 | 33.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
11.2 | 134.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
11.2 | 44.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
11.1 | 44.5 | GO:0030091 | protein repair(GO:0030091) |
11.1 | 22.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
11.1 | 22.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
11.0 | 11.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
11.0 | 22.0 | GO:0008355 | olfactory learning(GO:0008355) |
11.0 | 43.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
10.9 | 21.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
10.9 | 130.3 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
10.9 | 54.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
10.8 | 32.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
10.8 | 32.3 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
10.8 | 64.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
10.8 | 32.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
10.7 | 96.7 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
10.6 | 21.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
10.6 | 42.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
10.6 | 31.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
10.6 | 31.8 | GO:0021854 | hypothalamus development(GO:0021854) |
10.6 | 10.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
10.6 | 21.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
10.6 | 31.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
10.6 | 21.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
10.5 | 42.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
10.5 | 52.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
10.5 | 63.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
10.5 | 21.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
10.5 | 31.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
10.4 | 114.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
10.4 | 20.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
10.3 | 41.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
10.3 | 31.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
10.3 | 20.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
10.2 | 61.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
10.2 | 30.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
10.2 | 10.2 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
10.2 | 10.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
10.2 | 10.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
10.1 | 10.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
10.1 | 10.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
10.1 | 10.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
10.1 | 20.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
10.1 | 70.4 | GO:0034331 | cell junction maintenance(GO:0034331) |
10.1 | 30.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
10.0 | 20.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
10.0 | 90.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
10.0 | 10.0 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
10.0 | 199.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
9.9 | 29.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
9.9 | 49.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
9.9 | 9.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
9.9 | 9.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
9.9 | 9.9 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
9.8 | 59.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
9.8 | 167.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
9.8 | 97.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
9.7 | 933.3 | GO:0097485 | neuron projection guidance(GO:0097485) |
9.7 | 29.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
9.7 | 29.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
9.7 | 48.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
9.6 | 19.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
9.6 | 86.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
9.6 | 38.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
9.5 | 19.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
9.5 | 28.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
9.5 | 19.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
9.5 | 18.9 | GO:0003150 | membranous septum morphogenesis(GO:0003149) muscular septum morphogenesis(GO:0003150) |
9.5 | 18.9 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
9.4 | 75.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
9.4 | 18.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
9.4 | 28.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
9.4 | 9.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
9.4 | 9.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
9.3 | 9.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
9.3 | 27.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
9.3 | 9.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
9.3 | 18.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
9.2 | 286.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
9.2 | 9.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
9.2 | 100.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
9.1 | 36.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
9.1 | 36.3 | GO:0060179 | male mating behavior(GO:0060179) |
9.0 | 18.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
9.0 | 9.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
9.0 | 17.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
8.9 | 62.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
8.9 | 17.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
8.9 | 44.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
8.9 | 133.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
8.9 | 26.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
8.8 | 88.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
8.8 | 17.6 | GO:0061055 | myotome development(GO:0061055) |
8.7 | 828.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
8.7 | 8.7 | GO:0032342 | aldosterone biosynthetic process(GO:0032342) |
8.7 | 8.7 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
8.7 | 60.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
8.7 | 17.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
8.6 | 8.6 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
8.6 | 60.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
8.6 | 69.0 | GO:0010842 | retina layer formation(GO:0010842) |
8.6 | 51.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
8.6 | 8.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
8.6 | 34.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
8.5 | 25.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
8.5 | 93.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
8.5 | 42.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
8.4 | 8.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
8.3 | 8.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
8.3 | 8.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
8.3 | 33.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
8.3 | 24.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
8.3 | 41.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
8.3 | 90.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
8.3 | 16.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
8.3 | 33.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
8.2 | 33.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
8.2 | 16.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
8.2 | 16.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
8.2 | 8.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
8.2 | 73.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
8.1 | 16.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
8.1 | 8.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
8.1 | 24.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
8.1 | 24.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
8.1 | 104.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
8.1 | 24.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
8.1 | 8.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
8.0 | 24.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
8.0 | 8.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
8.0 | 8.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
8.0 | 16.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
7.9 | 7.9 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
7.9 | 23.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
7.9 | 39.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
7.9 | 7.9 | GO:0021794 | thalamus development(GO:0021794) |
7.8 | 15.7 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
7.8 | 15.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
7.7 | 7.7 | GO:0070986 | left/right axis specification(GO:0070986) |
7.7 | 38.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
7.6 | 91.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
7.6 | 22.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
7.6 | 22.7 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
7.6 | 83.2 | GO:0036065 | fucosylation(GO:0036065) |
7.6 | 52.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
7.5 | 22.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
7.5 | 37.5 | GO:0031000 | response to caffeine(GO:0031000) |
7.5 | 7.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
7.5 | 15.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.5 | 15.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
7.5 | 44.8 | GO:0060736 | prostate gland growth(GO:0060736) |
7.4 | 37.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
7.4 | 52.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
7.4 | 7.4 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
7.4 | 29.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
7.4 | 14.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
7.3 | 21.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
7.2 | 14.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
7.2 | 14.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
7.2 | 21.6 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
7.2 | 7.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
7.2 | 28.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
7.2 | 43.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
7.1 | 7.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
7.1 | 35.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
7.1 | 7.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
7.1 | 28.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
7.1 | 28.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
7.1 | 21.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
7.1 | 49.4 | GO:0006108 | malate metabolic process(GO:0006108) |
7.0 | 28.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
7.0 | 14.1 | GO:0030432 | peristalsis(GO:0030432) |
7.0 | 21.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
7.0 | 21.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
7.0 | 7.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
7.0 | 13.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
7.0 | 7.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
7.0 | 20.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
7.0 | 41.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
6.9 | 13.8 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
6.9 | 96.5 | GO:0007416 | synapse assembly(GO:0007416) |
6.9 | 13.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
6.8 | 20.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
6.8 | 27.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
6.7 | 13.5 | GO:0048854 | brain morphogenesis(GO:0048854) |
6.7 | 6.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
6.7 | 20.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
6.7 | 33.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
6.7 | 33.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
6.7 | 33.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
6.7 | 86.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
6.6 | 13.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
6.6 | 19.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
6.6 | 13.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
6.5 | 26.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
6.5 | 19.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
6.5 | 52.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
6.5 | 39.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
6.5 | 32.4 | GO:0015884 | folic acid transport(GO:0015884) |
6.5 | 6.5 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
6.4 | 12.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
6.4 | 6.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
6.4 | 6.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
6.4 | 19.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
6.4 | 287.3 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
6.4 | 19.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
6.4 | 19.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
6.4 | 19.1 | GO:0006868 | glutamine transport(GO:0006868) |
6.4 | 6.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
6.3 | 19.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
6.3 | 6.3 | GO:0042938 | dipeptide transport(GO:0042938) |
6.3 | 31.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
6.3 | 25.2 | GO:0033762 | response to glucagon(GO:0033762) |
6.2 | 106.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
6.2 | 12.5 | GO:0048664 | neuron fate determination(GO:0048664) |
6.2 | 6.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
6.2 | 24.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
6.2 | 30.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
6.2 | 30.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
6.2 | 172.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
6.1 | 18.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
6.1 | 18.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
6.1 | 49.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
6.1 | 24.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
6.1 | 42.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
6.1 | 18.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
6.0 | 6.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
6.0 | 35.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
6.0 | 11.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
5.9 | 11.9 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
5.9 | 59.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
5.9 | 29.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
5.9 | 17.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
5.9 | 11.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
5.9 | 5.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
5.9 | 47.0 | GO:0007588 | excretion(GO:0007588) |
5.9 | 5.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
5.9 | 11.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
5.9 | 76.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
5.9 | 17.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
5.9 | 11.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
5.8 | 134.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
5.8 | 11.6 | GO:0015888 | thiamine transport(GO:0015888) |
5.8 | 29.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
5.8 | 11.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
5.8 | 5.8 | GO:0051665 | membrane raft localization(GO:0051665) |
5.8 | 23.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
5.7 | 17.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
5.7 | 22.7 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
5.7 | 34.1 | GO:0060004 | reflex(GO:0060004) |
5.6 | 11.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
5.6 | 11.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
5.5 | 5.5 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
5.5 | 5.5 | GO:0072174 | metanephric tubule formation(GO:0072174) |
5.5 | 11.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
5.5 | 38.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
5.5 | 60.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
5.5 | 5.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
5.5 | 11.0 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
5.5 | 16.4 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) |
5.5 | 10.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
5.4 | 21.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
5.4 | 37.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
5.4 | 53.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
5.4 | 10.8 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
5.4 | 10.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
5.4 | 10.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
5.3 | 5.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
5.3 | 37.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
5.3 | 26.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
5.3 | 10.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
5.3 | 26.4 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
5.3 | 21.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
5.2 | 5.2 | GO:0034205 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) regulation of amyloid precursor protein catabolic process(GO:1902991) |
5.2 | 57.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
5.2 | 25.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
5.2 | 10.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
5.1 | 5.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
5.1 | 30.8 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
5.1 | 5.1 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
5.1 | 10.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
5.1 | 45.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
5.1 | 30.4 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
5.1 | 5.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
5.0 | 5.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
5.0 | 30.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
5.0 | 10.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
5.0 | 5.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
5.0 | 15.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
5.0 | 59.8 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
5.0 | 19.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
5.0 | 5.0 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
4.9 | 4.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
4.9 | 4.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
4.9 | 14.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
4.9 | 29.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
4.9 | 9.8 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
4.9 | 9.8 | GO:1990403 | embryonic brain development(GO:1990403) |
4.9 | 19.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
4.9 | 4.9 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
4.9 | 4.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
4.9 | 4.9 | GO:0060872 | semicircular canal development(GO:0060872) |
4.8 | 9.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
4.8 | 4.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
4.8 | 67.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
4.8 | 9.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
4.8 | 9.5 | GO:0003096 | renal sodium ion transport(GO:0003096) |
4.8 | 19.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
4.8 | 4.8 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
4.7 | 14.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
4.7 | 9.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
4.7 | 23.6 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
4.7 | 4.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.7 | 4.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
4.7 | 18.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
4.7 | 4.7 | GO:0046051 | UTP metabolic process(GO:0046051) |
4.7 | 14.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
4.7 | 9.3 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
4.6 | 55.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
4.6 | 4.6 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
4.6 | 9.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
4.6 | 18.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
4.6 | 9.2 | GO:0021554 | optic nerve development(GO:0021554) |
4.6 | 4.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
4.6 | 18.3 | GO:0008347 | glial cell migration(GO:0008347) |
4.6 | 9.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
4.6 | 86.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
4.6 | 27.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
4.5 | 4.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
4.5 | 13.6 | GO:0032835 | glomerulus development(GO:0032835) |
4.5 | 9.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
4.5 | 4.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
4.4 | 8.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
4.4 | 13.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
4.4 | 84.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
4.4 | 17.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
4.4 | 4.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
4.4 | 13.2 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.4 | 30.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
4.4 | 69.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
4.4 | 13.1 | GO:0070459 | prolactin secretion(GO:0070459) |
4.3 | 8.7 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
4.3 | 8.7 | GO:0050955 | thermoception(GO:0050955) |
4.3 | 8.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
4.3 | 21.7 | GO:0016322 | neuron remodeling(GO:0016322) |
4.3 | 13.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
4.3 | 4.3 | GO:1903416 | response to glycoside(GO:1903416) |
4.3 | 25.9 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
4.3 | 12.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
4.3 | 8.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
4.3 | 12.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
4.3 | 12.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
4.2 | 8.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
4.2 | 16.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
4.2 | 29.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
4.2 | 25.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
4.2 | 16.8 | GO:0051450 | myoblast proliferation(GO:0051450) |
4.2 | 4.2 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
4.2 | 25.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
4.2 | 62.4 | GO:0006491 | N-glycan processing(GO:0006491) |
4.2 | 45.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
4.1 | 4.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
4.1 | 12.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
4.1 | 37.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
4.1 | 8.3 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
4.1 | 4.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
4.1 | 24.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
4.1 | 24.6 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
4.1 | 61.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
4.1 | 8.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
4.1 | 12.2 | GO:0051639 | actin filament network formation(GO:0051639) |
4.0 | 8.1 | GO:0051013 | microtubule severing(GO:0051013) |
4.0 | 4.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
4.0 | 20.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
4.0 | 4.0 | GO:0033504 | floor plate development(GO:0033504) |
4.0 | 8.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
4.0 | 7.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
4.0 | 4.0 | GO:0046541 | saliva secretion(GO:0046541) |
3.9 | 23.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
3.9 | 3.9 | GO:0032306 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) |
3.9 | 19.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
3.9 | 3.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
3.9 | 34.9 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
3.9 | 7.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
3.9 | 34.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
3.9 | 7.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
3.9 | 11.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
3.8 | 11.5 | GO:0051647 | nucleus localization(GO:0051647) |
3.8 | 7.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
3.8 | 11.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
3.8 | 19.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
3.8 | 3.8 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
3.8 | 11.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
3.8 | 11.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
3.7 | 3.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
3.7 | 33.7 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
3.7 | 7.5 | GO:0019042 | viral latency(GO:0019042) |
3.7 | 14.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
3.7 | 14.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.7 | 7.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
3.7 | 22.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
3.7 | 7.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
3.7 | 18.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
3.7 | 7.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
3.6 | 3.6 | GO:0061548 | ganglion development(GO:0061548) |
3.6 | 7.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
3.6 | 14.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
3.6 | 10.9 | GO:0002934 | desmosome organization(GO:0002934) |
3.6 | 3.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
3.6 | 3.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
3.6 | 28.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
3.6 | 14.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
3.6 | 3.6 | GO:0042637 | catagen(GO:0042637) |
3.6 | 3.6 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
3.6 | 32.1 | GO:0045056 | transcytosis(GO:0045056) |
3.5 | 14.2 | GO:0060914 | heart formation(GO:0060914) |
3.5 | 3.5 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
3.5 | 10.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
3.5 | 3.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.5 | 108.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
3.5 | 10.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
3.5 | 17.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
3.5 | 13.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
3.5 | 20.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
3.5 | 13.8 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) |
3.4 | 10.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
3.4 | 6.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
3.4 | 3.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
3.4 | 3.4 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
3.4 | 13.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
3.4 | 23.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
3.4 | 20.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
3.4 | 10.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
3.4 | 13.5 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
3.4 | 10.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
3.4 | 6.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
3.4 | 16.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
3.4 | 10.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
3.3 | 23.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
3.3 | 10.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
3.3 | 20.0 | GO:0007135 | meiosis II(GO:0007135) |
3.3 | 3.3 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
3.3 | 9.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
3.3 | 29.7 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
3.3 | 6.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.3 | 3.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
3.3 | 16.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
3.3 | 3.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
3.3 | 22.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
3.3 | 9.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
3.3 | 3.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
3.2 | 6.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
3.2 | 22.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
3.2 | 68.1 | GO:0034605 | cellular response to heat(GO:0034605) |
3.2 | 16.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
3.2 | 12.8 | GO:0035627 | ceramide transport(GO:0035627) |
3.2 | 3.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
3.2 | 19.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
3.2 | 3.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.2 | 3.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
3.2 | 9.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
3.1 | 25.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
3.1 | 3.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
3.1 | 9.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
3.1 | 28.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
3.1 | 9.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
3.1 | 18.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
3.1 | 28.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
3.1 | 9.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
3.1 | 6.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
3.1 | 18.6 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
3.1 | 130.5 | GO:0001764 | neuron migration(GO:0001764) |
3.1 | 43.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
3.1 | 33.7 | GO:0015844 | monoamine transport(GO:0015844) |
3.1 | 18.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
3.1 | 6.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
3.1 | 6.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
3.1 | 9.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
3.1 | 3.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
3.0 | 18.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
3.0 | 33.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
3.0 | 9.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
3.0 | 6.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
3.0 | 6.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
3.0 | 12.0 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
3.0 | 59.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
3.0 | 14.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
3.0 | 14.9 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
3.0 | 240.7 | GO:0007409 | axonogenesis(GO:0007409) |
3.0 | 3.0 | GO:0003157 | endocardium development(GO:0003157) |
3.0 | 14.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
3.0 | 14.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.9 | 2.9 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.9 | 8.8 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
2.9 | 11.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
2.9 | 11.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
2.9 | 2.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.9 | 5.8 | GO:0048254 | snoRNA localization(GO:0048254) |
2.9 | 11.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
2.9 | 2.9 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
2.8 | 2.8 | GO:0002339 | B cell selection(GO:0002339) |
2.8 | 5.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.8 | 11.2 | GO:0015824 | proline transport(GO:0015824) |
2.8 | 8.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
2.8 | 5.6 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
2.8 | 2.8 | GO:0033058 | directional locomotion(GO:0033058) |
2.8 | 8.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
2.8 | 2.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
2.8 | 5.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.8 | 13.8 | GO:0051451 | myoblast migration(GO:0051451) |
2.8 | 5.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
2.8 | 5.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
2.7 | 8.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
2.7 | 8.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.7 | 13.5 | GO:0001508 | action potential(GO:0001508) |
2.7 | 18.9 | GO:0010224 | response to UV-B(GO:0010224) |
2.7 | 8.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.7 | 26.8 | GO:0003334 | keratinocyte development(GO:0003334) |
2.7 | 147.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
2.7 | 2.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.7 | 5.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
2.7 | 15.9 | GO:0097484 | dendrite extension(GO:0097484) |
2.6 | 2.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
2.6 | 2.6 | GO:0015705 | iodide transport(GO:0015705) |
2.6 | 5.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
2.6 | 18.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
2.6 | 15.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.6 | 10.5 | GO:0007379 | segment specification(GO:0007379) |
2.6 | 2.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
2.6 | 10.4 | GO:0031103 | axon regeneration(GO:0031103) |
2.6 | 7.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
2.6 | 2.6 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
2.6 | 30.9 | GO:0015858 | nucleoside transport(GO:0015858) |
2.6 | 18.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
2.6 | 18.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.6 | 7.7 | GO:0015747 | urate transport(GO:0015747) |
2.5 | 10.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.5 | 2.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
2.5 | 2.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
2.5 | 43.2 | GO:0007340 | acrosome reaction(GO:0007340) |
2.5 | 45.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
2.5 | 5.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.5 | 5.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
2.5 | 5.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
2.5 | 20.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
2.5 | 7.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
2.5 | 2.5 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
2.5 | 2.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.5 | 10.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
2.5 | 5.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
2.5 | 5.0 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
2.5 | 27.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
2.5 | 9.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
2.5 | 2.5 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
2.5 | 7.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
2.5 | 2.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.4 | 7.3 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
2.4 | 4.9 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
2.4 | 4.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
2.4 | 4.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
2.4 | 2.4 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
2.4 | 19.3 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
2.4 | 2.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
2.4 | 7.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
2.4 | 14.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
2.4 | 11.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
2.4 | 7.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.4 | 21.2 | GO:0046677 | response to antibiotic(GO:0046677) |
2.3 | 4.7 | GO:0048069 | eye pigmentation(GO:0048069) |
2.3 | 4.7 | GO:0031296 | B cell costimulation(GO:0031296) |
2.3 | 2.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
2.3 | 30.0 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
2.3 | 2.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
2.3 | 4.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.3 | 4.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.3 | 24.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
2.3 | 4.5 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
2.3 | 9.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.2 | 4.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.2 | 17.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
2.2 | 31.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.2 | 4.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
2.2 | 8.9 | GO:0007614 | short-term memory(GO:0007614) |
2.2 | 6.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.2 | 4.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.2 | 8.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.2 | 6.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
2.2 | 13.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
2.2 | 2.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
2.2 | 2.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
2.1 | 4.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.1 | 4.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.1 | 17.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.1 | 4.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
2.1 | 6.4 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
2.1 | 2.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
2.1 | 8.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
2.1 | 2.1 | GO:0090148 | membrane fission(GO:0090148) |
2.1 | 10.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.1 | 4.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
2.1 | 16.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
2.1 | 8.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
2.1 | 2.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.1 | 4.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
2.1 | 4.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
2.0 | 6.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.0 | 2.0 | GO:0015846 | polyamine transport(GO:0015846) |
2.0 | 8.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
2.0 | 2.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
2.0 | 2.0 | GO:0035878 | nail development(GO:0035878) |
2.0 | 9.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
2.0 | 5.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.0 | 2.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.0 | 5.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.0 | 2.0 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.0 | 13.7 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
2.0 | 5.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.9 | 19.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
1.9 | 5.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.9 | 15.5 | GO:0030575 | nuclear body organization(GO:0030575) |
1.9 | 1.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.9 | 27.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.9 | 1.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.9 | 5.8 | GO:0015819 | lysine transport(GO:0015819) |
1.9 | 3.9 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.9 | 15.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
1.9 | 11.5 | GO:0015074 | DNA integration(GO:0015074) |
1.9 | 1.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.9 | 15.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.9 | 34.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.9 | 9.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.9 | 3.7 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.9 | 1.9 | GO:0072044 | collecting duct development(GO:0072044) |
1.9 | 1.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.9 | 11.2 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
1.9 | 31.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
1.8 | 1.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.8 | 7.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.8 | 7.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.8 | 44.0 | GO:0050808 | synapse organization(GO:0050808) |
1.8 | 1.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.8 | 12.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.8 | 9.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.8 | 7.2 | GO:0001736 | establishment of planar polarity(GO:0001736) |
1.8 | 3.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.8 | 12.5 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
1.8 | 3.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.8 | 8.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
1.7 | 3.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.7 | 6.9 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.7 | 20.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
1.7 | 5.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.7 | 8.6 | GO:0006983 | ER overload response(GO:0006983) |
1.7 | 1.7 | GO:1903998 | regulation of eating behavior(GO:1903998) |
1.7 | 8.6 | GO:0014002 | astrocyte development(GO:0014002) |
1.7 | 3.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.7 | 5.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.7 | 1.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.7 | 1.7 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
1.7 | 1.7 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
1.7 | 23.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
1.7 | 15.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.7 | 11.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.7 | 3.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.7 | 3.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.7 | 5.0 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
1.6 | 4.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.6 | 8.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
1.6 | 35.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
1.6 | 17.8 | GO:0034389 | lipid particle organization(GO:0034389) |
1.6 | 4.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.6 | 8.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.6 | 8.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
1.6 | 14.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
1.6 | 8.0 | GO:0030903 | notochord development(GO:0030903) |
1.6 | 6.4 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
1.6 | 1.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.6 | 3.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.6 | 1.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.6 | 6.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.6 | 11.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.6 | 14.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.6 | 3.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
1.6 | 3.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.6 | 3.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.6 | 1.6 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.6 | 3.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.6 | 4.7 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
1.5 | 7.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.5 | 4.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.5 | 6.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.5 | 6.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
1.5 | 10.8 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
1.5 | 10.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.5 | 1.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.5 | 3.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.5 | 6.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.5 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.5 | 47.7 | GO:0016358 | dendrite development(GO:0016358) |
1.5 | 4.5 | GO:0046785 | microtubule polymerization(GO:0046785) |
1.5 | 3.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.5 | 3.0 | GO:0090383 | phagosome acidification(GO:0090383) |
1.5 | 11.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.5 | 37.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.5 | 3.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.5 | 10.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.5 | 1.5 | GO:0043586 | tongue development(GO:0043586) |
1.5 | 2.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.5 | 13.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
1.4 | 59.2 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
1.4 | 7.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 2.9 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.4 | 25.9 | GO:0046847 | filopodium assembly(GO:0046847) |
1.4 | 7.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.4 | 7.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
1.4 | 28.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.4 | 4.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.4 | 4.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
1.4 | 4.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.4 | 5.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.4 | 7.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.4 | 4.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.4 | 8.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
1.4 | 6.9 | GO:0097009 | energy homeostasis(GO:0097009) |
1.4 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.4 | 12.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.4 | 4.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.4 | 2.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.4 | 23.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
1.4 | 2.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.4 | 5.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.3 | 1.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.3 | 15.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.3 | 29.9 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
1.3 | 3.9 | GO:1904377 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.3 | 8.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.3 | 17.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
1.3 | 3.8 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
1.3 | 2.5 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
1.2 | 2.5 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
1.2 | 10.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.2 | 2.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.2 | 3.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.2 | 3.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 2.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.2 | 23.4 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
1.2 | 8.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.2 | 1.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
1.2 | 6.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
1.2 | 8.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
1.2 | 7.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
1.2 | 2.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.2 | 1.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.2 | 1.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
1.2 | 7.2 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
1.2 | 12.0 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
1.2 | 8.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.2 | 9.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.2 | 4.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.2 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.2 | 13.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
1.2 | 5.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
1.2 | 15.3 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
1.2 | 3.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.2 | 1.2 | GO:0060459 | left lung development(GO:0060459) |
1.2 | 2.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.2 | 2.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.2 | 3.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.2 | 25.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.1 | 3.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.1 | 4.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.1 | 6.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.1 | 3.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.1 | 11.3 | GO:0048240 | sperm capacitation(GO:0048240) |
1.1 | 1.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.1 | 3.4 | GO:0006562 | proline catabolic process(GO:0006562) |
1.1 | 10.1 | GO:0030539 | male genitalia development(GO:0030539) |
1.1 | 1.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 2.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.1 | 4.4 | GO:0061337 | cardiac conduction(GO:0061337) |
1.1 | 2.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.1 | 1.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.1 | 4.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.1 | 4.3 | GO:0018158 | protein oxidation(GO:0018158) |
1.1 | 17.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.1 | 6.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
1.1 | 1.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.1 | 16.8 | GO:0006813 | potassium ion transport(GO:0006813) |
1.0 | 4.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.0 | 3.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.0 | 4.1 | GO:0097435 | fibril organization(GO:0097435) |
1.0 | 3.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.0 | 6.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.0 | 13.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.0 | 3.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
1.0 | 11.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
1.0 | 19.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
1.0 | 3.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.0 | 1.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
1.0 | 2.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.0 | 8.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.0 | 3.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
1.0 | 1.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
1.0 | 1.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.9 | 1.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.9 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.9 | 3.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.9 | 0.9 | GO:0014889 | muscle atrophy(GO:0014889) |
0.9 | 7.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.9 | 2.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.9 | 0.9 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.9 | 2.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.9 | 1.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 1.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 15.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.9 | 0.9 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.9 | 2.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.9 | 9.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.9 | 0.9 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.9 | 0.9 | GO:0009750 | response to fructose(GO:0009750) |
0.9 | 1.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 13.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.9 | 0.9 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.9 | 4.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 4.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.8 | 2.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 3.4 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.8 | 185.7 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.8 | 1.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 1.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.8 | 2.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 2.5 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.8 | 2.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.8 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 2.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.8 | 2.5 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.8 | 4.9 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.8 | 2.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.8 | 4.8 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.8 | 4.0 | GO:0042551 | neuron maturation(GO:0042551) |
0.8 | 7.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.8 | 3.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.8 | 3.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.8 | 7.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.8 | 8.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.8 | 8.5 | GO:0008542 | visual learning(GO:0008542) |
0.8 | 1.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.7 | 10.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.7 | 3.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.7 | 15.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.7 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.7 | 0.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.7 | 0.7 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.7 | 0.7 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.7 | 1.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.7 | 0.7 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.7 | 4.8 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.7 | 2.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.7 | 1.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 0.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.6 | 9.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.6 | 0.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 3.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 1.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.6 | 14.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 1.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.6 | 3.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.6 | 0.6 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 4.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.6 | 1.2 | GO:0060746 | parental behavior(GO:0060746) |
0.6 | 0.6 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.6 | 1.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 1.7 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.6 | 2.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 4.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 1.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 0.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 3.2 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.5 | 1.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 2.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.5 | 0.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.5 | 1.6 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.5 | 4.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.5 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 12.2 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.5 | 0.5 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.5 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.5 | 0.5 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 4.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.5 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.5 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.5 | 1.0 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.5 | 1.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.5 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 2.7 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.4 | 3.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 0.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.4 | 13.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.4 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.4 | 2.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 7.5 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.4 | 13.7 | GO:0099536 | synaptic signaling(GO:0099536) |
0.4 | 1.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 2.7 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.4 | 9.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 1.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 1.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.7 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 15.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.3 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.9 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.4 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.2 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.2 | 1.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 2.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 1.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 3.9 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.2 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.5 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.3 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) cellular response to copper ion(GO:0071280) cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 5.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 13.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 3.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 2.1 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.1 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 1.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 107.2 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
53.7 | 161.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
32.5 | 195.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
31.7 | 158.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
31.4 | 94.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
29.9 | 298.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
29.5 | 147.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
28.6 | 114.2 | GO:0044308 | axonal spine(GO:0044308) |
28.0 | 308.5 | GO:0043194 | axon initial segment(GO:0043194) |
28.0 | 812.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
27.8 | 27.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
25.5 | 25.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
24.0 | 336.1 | GO:0030673 | axolemma(GO:0030673) |
23.9 | 23.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
23.3 | 793.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
22.6 | 384.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
21.0 | 63.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
20.4 | 20.4 | GO:0005883 | neurofilament(GO:0005883) |
20.4 | 529.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
20.3 | 162.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
20.1 | 220.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
19.7 | 59.1 | GO:0072534 | perineuronal net(GO:0072534) |
19.1 | 19.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
18.9 | 94.7 | GO:0043083 | synaptic cleft(GO:0043083) |
18.9 | 56.6 | GO:0043511 | inhibin complex(GO:0043511) |
18.7 | 18.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
18.5 | 111.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
17.7 | 159.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
17.5 | 34.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
17.4 | 52.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
16.4 | 411.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
16.4 | 65.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
16.1 | 64.5 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
16.0 | 16.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
15.8 | 47.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
15.6 | 46.9 | GO:0097427 | microtubule bundle(GO:0097427) |
15.3 | 45.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
14.8 | 59.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
14.3 | 816.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
13.7 | 41.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
13.5 | 40.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
13.3 | 146.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
13.2 | 39.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
13.1 | 65.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
12.8 | 448.6 | GO:0043198 | dendritic shaft(GO:0043198) |
12.8 | 12.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
12.7 | 88.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
12.5 | 125.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
12.4 | 37.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
12.1 | 145.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
12.0 | 12.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
11.9 | 1565.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
11.9 | 23.8 | GO:0044393 | microspike(GO:0044393) |
11.3 | 45.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
11.1 | 44.2 | GO:0043219 | lateral loop(GO:0043219) |
11.0 | 65.8 | GO:0005915 | zonula adherens(GO:0005915) |
10.8 | 172.3 | GO:0044295 | axonal growth cone(GO:0044295) |
10.7 | 64.2 | GO:0032584 | growth cone membrane(GO:0032584) |
10.7 | 64.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
10.7 | 21.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
10.6 | 10.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
10.5 | 31.6 | GO:0030478 | actin cap(GO:0030478) |
10.4 | 51.9 | GO:0031901 | early endosome membrane(GO:0031901) |
10.3 | 51.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
10.3 | 1084.1 | GO:0060076 | excitatory synapse(GO:0060076) |
10.2 | 40.9 | GO:0097433 | dense body(GO:0097433) |
10.1 | 120.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
9.9 | 19.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
9.7 | 9.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
9.6 | 115.7 | GO:0031045 | dense core granule(GO:0031045) |
9.6 | 105.5 | GO:0001527 | microfibril(GO:0001527) |
9.3 | 18.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
9.3 | 18.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
9.1 | 64.0 | GO:0031209 | SCAR complex(GO:0031209) |
8.9 | 8.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
8.6 | 17.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
8.3 | 83.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
8.2 | 49.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
8.1 | 97.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
8.0 | 47.7 | GO:0097449 | astrocyte projection(GO:0097449) |
7.9 | 63.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
7.9 | 110.8 | GO:0044298 | cell body membrane(GO:0044298) |
7.8 | 31.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
7.8 | 117.4 | GO:0005614 | interstitial matrix(GO:0005614) |
7.8 | 622.4 | GO:0030426 | growth cone(GO:0030426) |
7.8 | 69.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
7.7 | 7.7 | GO:0042629 | mast cell granule(GO:0042629) |
7.6 | 22.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
7.6 | 22.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
7.6 | 90.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
7.2 | 433.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
7.2 | 21.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
7.1 | 7.1 | GO:0016600 | flotillin complex(GO:0016600) |
7.1 | 28.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
7.1 | 84.8 | GO:0034704 | calcium channel complex(GO:0034704) |
7.1 | 303.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
7.0 | 21.0 | GO:0033010 | paranodal junction(GO:0033010) |
6.8 | 6.8 | GO:0032280 | symmetric synapse(GO:0032280) |
6.8 | 245.7 | GO:0098794 | postsynapse(GO:0098794) |
6.8 | 921.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
6.7 | 20.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
6.4 | 1660.3 | GO:0045202 | synapse(GO:0045202) |
6.4 | 25.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
6.2 | 56.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
6.1 | 24.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
6.0 | 6.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
5.8 | 5.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
5.8 | 11.5 | GO:0097546 | ciliary base(GO:0097546) |
5.7 | 33.9 | GO:0001652 | granular component(GO:0001652) |
5.6 | 11.2 | GO:0097441 | basilar dendrite(GO:0097441) |
5.6 | 11.2 | GO:0033503 | HULC complex(GO:0033503) |
5.4 | 16.2 | GO:1990393 | 3M complex(GO:1990393) |
5.3 | 15.9 | GO:0042583 | chromaffin granule(GO:0042583) |
5.3 | 47.5 | GO:0031512 | motile primary cilium(GO:0031512) |
5.2 | 46.7 | GO:0000124 | SAGA complex(GO:0000124) |
5.0 | 20.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
5.0 | 5.0 | GO:0097386 | glial cell projection(GO:0097386) |
5.0 | 44.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
4.9 | 29.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
4.9 | 14.8 | GO:0043256 | laminin-5 complex(GO:0005610) laminin complex(GO:0043256) |
4.9 | 19.5 | GO:0097440 | apical dendrite(GO:0097440) |
4.9 | 19.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
4.8 | 23.9 | GO:0031143 | pseudopodium(GO:0031143) |
4.8 | 4.8 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
4.6 | 4.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
4.5 | 58.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
4.4 | 13.3 | GO:0071203 | WASH complex(GO:0071203) |
4.4 | 13.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
4.4 | 34.8 | GO:0036156 | inner dynein arm(GO:0036156) |
4.3 | 8.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.3 | 21.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
4.3 | 12.8 | GO:0048179 | activin receptor complex(GO:0048179) |
4.2 | 17.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
4.2 | 127.4 | GO:0005581 | collagen trimer(GO:0005581) |
4.2 | 121.6 | GO:0030175 | filopodium(GO:0030175) |
4.1 | 24.8 | GO:0044292 | dendrite terminus(GO:0044292) |
4.1 | 49.5 | GO:0046930 | pore complex(GO:0046930) |
4.0 | 28.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
4.0 | 20.1 | GO:0032590 | dendrite membrane(GO:0032590) |
3.9 | 7.9 | GO:0005955 | calcineurin complex(GO:0005955) |
3.9 | 39.0 | GO:0071564 | npBAF complex(GO:0071564) |
3.9 | 19.4 | GO:0070695 | FHF complex(GO:0070695) |
3.9 | 30.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
3.8 | 15.3 | GO:0070876 | SOSS complex(GO:0070876) |
3.8 | 7.6 | GO:1990635 | proximal dendrite(GO:1990635) |
3.8 | 3.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.8 | 45.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
3.8 | 11.3 | GO:0071942 | XPC complex(GO:0071942) |
3.8 | 11.3 | GO:0000235 | astral microtubule(GO:0000235) |
3.6 | 14.5 | GO:0032021 | NELF complex(GO:0032021) |
3.6 | 18.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
3.6 | 10.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
3.5 | 3.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
3.5 | 45.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
3.4 | 10.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.4 | 10.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.4 | 68.6 | GO:0030315 | T-tubule(GO:0030315) |
3.3 | 797.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
3.3 | 10.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.3 | 16.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
3.3 | 6.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
3.3 | 13.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
3.3 | 3.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.1 | 9.4 | GO:0097422 | tubular endosome(GO:0097422) |
3.1 | 31.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
3.1 | 6.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
3.1 | 6.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
3.0 | 81.3 | GO:0005921 | gap junction(GO:0005921) |
3.0 | 147.1 | GO:0043204 | perikaryon(GO:0043204) |
3.0 | 12.0 | GO:0070545 | PeBoW complex(GO:0070545) |
2.9 | 40.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
2.9 | 8.7 | GO:0030427 | site of polarized growth(GO:0030427) |
2.9 | 2.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
2.9 | 11.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
2.9 | 23.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
2.9 | 97.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
2.9 | 14.3 | GO:0071547 | piP-body(GO:0071547) |
2.9 | 31.4 | GO:0016460 | myosin II complex(GO:0016460) |
2.8 | 11.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
2.8 | 19.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
2.8 | 41.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.7 | 30.2 | GO:0042555 | MCM complex(GO:0042555) |
2.7 | 115.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
2.7 | 15.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
2.6 | 57.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
2.6 | 18.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
2.6 | 10.4 | GO:0097342 | ripoptosome(GO:0097342) |
2.6 | 31.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
2.6 | 35.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.6 | 7.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.6 | 10.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.5 | 15.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.5 | 5.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
2.5 | 5.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.5 | 10.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
2.5 | 12.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
2.5 | 293.2 | GO:0030424 | axon(GO:0030424) |
2.5 | 12.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
2.4 | 36.6 | GO:0030057 | desmosome(GO:0030057) |
2.4 | 4.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.4 | 14.4 | GO:0016589 | NURF complex(GO:0016589) |
2.4 | 4.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
2.4 | 4.8 | GO:0045178 | basal part of cell(GO:0045178) |
2.4 | 11.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.4 | 7.1 | GO:0072687 | meiotic spindle(GO:0072687) |
2.4 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.3 | 11.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
2.3 | 105.2 | GO:0031012 | extracellular matrix(GO:0031012) |
2.3 | 2.3 | GO:0070820 | tertiary granule(GO:0070820) |
2.3 | 23.1 | GO:0030904 | retromer complex(GO:0030904) |
2.3 | 34.3 | GO:0001741 | XY body(GO:0001741) |
2.3 | 220.6 | GO:0030425 | dendrite(GO:0030425) |
2.3 | 56.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
2.2 | 22.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.2 | 11.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.2 | 28.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
2.2 | 248.0 | GO:0043005 | neuron projection(GO:0043005) |
2.2 | 6.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
2.2 | 2.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.1 | 126.8 | GO:0043025 | neuronal cell body(GO:0043025) |
2.1 | 10.5 | GO:0044447 | axoneme part(GO:0044447) |
2.1 | 4.1 | GO:0005796 | Golgi lumen(GO:0005796) |
2.0 | 71.0 | GO:0043296 | apical junction complex(GO:0043296) |
2.0 | 23.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
2.0 | 15.8 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
2.0 | 13.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.8 | 1.8 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
1.8 | 7.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.8 | 5.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.7 | 53.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.7 | 5.1 | GO:0036396 | MIS complex(GO:0036396) |
1.7 | 8.4 | GO:0071439 | clathrin complex(GO:0071439) |
1.7 | 18.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.7 | 5.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.6 | 9.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.6 | 1.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.6 | 72.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
1.6 | 3.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.6 | 8.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.6 | 4.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.6 | 6.3 | GO:0045180 | basal cortex(GO:0045180) |
1.6 | 4.7 | GO:0001520 | outer dense fiber(GO:0001520) |
1.6 | 32.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.5 | 6.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.5 | 1.5 | GO:1990357 | terminal web(GO:1990357) |
1.5 | 34.5 | GO:0032432 | actin filament bundle(GO:0032432) |
1.5 | 4.5 | GO:0071817 | MMXD complex(GO:0071817) |
1.5 | 8.9 | GO:0030008 | TRAPP complex(GO:0030008) |
1.4 | 5.8 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.4 | 4.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.4 | 6294.0 | GO:0016021 | integral component of membrane(GO:0016021) |
1.4 | 4.2 | GO:0031201 | SNARE complex(GO:0031201) |
1.4 | 4.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.4 | 23.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.4 | 2.7 | GO:0071797 | LUBAC complex(GO:0071797) |
1.3 | 2.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.3 | 41.1 | GO:0030027 | lamellipodium(GO:0030027) |
1.3 | 22.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.3 | 5.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.3 | 72.6 | GO:0043209 | myelin sheath(GO:0043209) |
1.2 | 4.7 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 4.7 | GO:0071546 | pi-body(GO:0071546) |
1.1 | 4.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.1 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
1.0 | 30.4 | GO:0030018 | Z disc(GO:0030018) |
1.0 | 127.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.0 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.0 | 7.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.0 | 26.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
1.0 | 27.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.0 | 13.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 3.7 | GO:0002177 | manchette(GO:0002177) |
0.9 | 5.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.9 | 15.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.9 | 36.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.8 | 2.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.8 | 0.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.8 | 0.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.8 | 6.4 | GO:0000800 | lateral element(GO:0000800) |
0.7 | 22.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.7 | 10.3 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.7 | 36.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.7 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.7 | 6.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.7 | 2.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 20.3 | GO:0031253 | cell projection membrane(GO:0031253) |
0.6 | 21.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.6 | 12.7 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 2.5 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.6 | 6.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.6 | 2.5 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.6 | 13.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 4.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.5 | 8.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 1.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 6.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.4 | 17.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 50.8 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 33.8 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 6.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 32.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 6.5 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 7.9 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
52.1 | 156.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
50.5 | 151.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
49.1 | 49.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
46.6 | 139.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
42.1 | 126.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
42.0 | 126.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
41.1 | 82.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
39.7 | 198.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
34.8 | 34.8 | GO:0038191 | neuropilin binding(GO:0038191) |
31.9 | 63.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
31.5 | 126.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
31.3 | 125.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
31.1 | 186.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
30.5 | 152.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
30.5 | 91.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
30.4 | 121.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
30.3 | 90.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
30.0 | 30.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
29.7 | 89.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
29.3 | 88.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
28.2 | 141.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
28.1 | 112.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
27.4 | 137.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
26.8 | 80.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
25.2 | 226.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
24.2 | 121.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
23.9 | 95.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
23.7 | 260.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
23.7 | 94.7 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
23.5 | 70.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
22.7 | 68.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
22.3 | 156.3 | GO:0003680 | AT DNA binding(GO:0003680) |
22.3 | 111.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
22.2 | 44.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
21.8 | 65.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
21.8 | 87.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
21.7 | 86.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
21.6 | 151.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
21.5 | 64.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
21.5 | 86.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
21.2 | 84.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
20.5 | 82.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
20.5 | 82.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
20.3 | 386.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
20.1 | 80.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
19.8 | 79.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
19.7 | 39.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
19.3 | 77.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
18.3 | 128.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
18.2 | 91.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
18.2 | 18.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
18.1 | 542.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
17.7 | 141.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
17.6 | 52.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
17.6 | 70.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
17.3 | 121.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
17.0 | 34.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
17.0 | 102.1 | GO:0048495 | Roundabout binding(GO:0048495) |
17.0 | 84.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
16.9 | 50.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
16.8 | 67.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
16.8 | 33.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
16.7 | 183.9 | GO:0005522 | profilin binding(GO:0005522) |
16.2 | 80.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
15.8 | 63.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
15.6 | 406.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
15.6 | 15.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
15.4 | 123.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
15.0 | 299.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
14.6 | 14.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
14.6 | 43.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
14.5 | 101.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
14.5 | 28.9 | GO:0097016 | L27 domain binding(GO:0097016) |
14.3 | 57.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
14.0 | 41.9 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
13.8 | 276.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
13.8 | 41.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
13.4 | 93.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
13.3 | 53.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
13.2 | 184.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
13.2 | 26.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
13.2 | 52.7 | GO:0070052 | collagen V binding(GO:0070052) |
13.2 | 52.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
13.1 | 13.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
13.1 | 39.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
12.8 | 321.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
12.6 | 25.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
12.6 | 50.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
12.5 | 125.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
12.5 | 37.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
12.4 | 49.5 | GO:0048185 | activin binding(GO:0048185) |
12.3 | 36.8 | GO:0035939 | microsatellite binding(GO:0035939) |
12.2 | 36.6 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
12.1 | 109.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
12.1 | 144.8 | GO:0031005 | filamin binding(GO:0031005) |
12.0 | 60.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
12.0 | 35.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
11.9 | 155.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
11.6 | 174.5 | GO:0030553 | cGMP binding(GO:0030553) |
11.5 | 69.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
11.4 | 68.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
11.3 | 45.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
11.3 | 113.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
11.3 | 11.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
11.2 | 326.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
11.2 | 11.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
11.1 | 22.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
11.1 | 55.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
11.0 | 44.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
11.0 | 77.0 | GO:0034711 | inhibin binding(GO:0034711) |
11.0 | 11.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
10.9 | 76.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
10.9 | 32.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
10.8 | 32.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
10.8 | 107.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
10.5 | 52.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
10.5 | 10.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
10.5 | 115.3 | GO:0015026 | coreceptor activity(GO:0015026) |
10.4 | 52.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
10.3 | 31.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
10.3 | 206.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
10.3 | 30.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
10.3 | 10.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
10.1 | 20.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
9.9 | 29.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
9.8 | 19.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
9.8 | 29.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
9.7 | 38.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
9.7 | 38.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
9.5 | 28.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
9.5 | 285.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
9.5 | 28.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
9.5 | 47.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
9.5 | 209.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
9.4 | 37.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
9.4 | 140.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
9.3 | 56.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
9.3 | 362.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
9.3 | 46.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
9.2 | 46.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
9.2 | 36.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
9.1 | 18.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
9.1 | 54.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
9.1 | 54.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
9.0 | 27.0 | GO:0051373 | FATZ binding(GO:0051373) |
9.0 | 35.9 | GO:0030506 | ankyrin binding(GO:0030506) |
8.9 | 62.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
8.9 | 80.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
8.9 | 17.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
8.8 | 53.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
8.8 | 79.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
8.8 | 26.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
8.7 | 26.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
8.7 | 69.9 | GO:0030955 | potassium ion binding(GO:0030955) |
8.7 | 34.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
8.7 | 26.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
8.7 | 69.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
8.6 | 120.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
8.5 | 170.8 | GO:0003785 | actin monomer binding(GO:0003785) |
8.3 | 8.3 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
8.2 | 33.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
8.2 | 139.9 | GO:0005112 | Notch binding(GO:0005112) |
8.1 | 40.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
8.1 | 24.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
8.0 | 32.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
7.9 | 302.0 | GO:0030276 | clathrin binding(GO:0030276) |
7.9 | 70.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
7.8 | 23.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
7.8 | 31.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
7.8 | 427.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
7.7 | 154.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
7.7 | 137.8 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
7.6 | 7.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
7.6 | 22.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
7.6 | 22.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
7.5 | 15.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
7.5 | 44.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
7.5 | 22.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
7.5 | 223.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
7.4 | 7.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
7.4 | 22.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
7.3 | 87.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
7.3 | 14.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
7.3 | 7.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
7.1 | 78.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
7.1 | 78.0 | GO:0005272 | sodium channel activity(GO:0005272) |
7.1 | 14.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
7.0 | 56.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
7.0 | 63.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
6.9 | 6.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
6.8 | 20.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
6.8 | 81.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
6.8 | 68.0 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
6.8 | 47.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
6.7 | 20.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
6.6 | 13.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
6.6 | 6.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
6.6 | 52.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
6.6 | 32.8 | GO:1990254 | keratin filament binding(GO:1990254) |
6.6 | 104.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
6.5 | 58.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
6.5 | 32.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
6.4 | 64.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
6.4 | 12.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
6.4 | 31.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
6.3 | 19.0 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
6.3 | 12.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
6.2 | 74.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
6.2 | 6.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
6.1 | 48.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
6.1 | 12.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
6.1 | 290.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
6.1 | 48.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
6.0 | 229.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
5.9 | 95.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
5.9 | 29.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
5.9 | 17.7 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
5.9 | 23.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
5.9 | 41.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
5.9 | 35.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
5.8 | 11.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
5.8 | 207.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
5.7 | 17.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
5.7 | 22.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.7 | 17.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
5.7 | 39.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
5.7 | 11.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
5.6 | 33.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
5.5 | 22.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
5.5 | 105.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
5.5 | 38.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
5.4 | 32.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
5.4 | 43.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
5.4 | 32.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
5.4 | 16.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
5.4 | 16.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
5.4 | 16.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
5.3 | 21.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
5.3 | 5.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) MAP kinase phosphatase activity(GO:0033549) |
5.3 | 10.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
5.3 | 74.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
5.3 | 15.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
5.2 | 15.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
5.2 | 26.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
5.2 | 156.2 | GO:0005109 | frizzled binding(GO:0005109) |
5.2 | 15.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
5.2 | 15.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
5.2 | 15.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
5.2 | 98.3 | GO:0070888 | E-box binding(GO:0070888) |
5.2 | 5.2 | GO:0045340 | mercury ion binding(GO:0045340) |
5.1 | 25.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
5.1 | 20.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
5.1 | 40.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
5.1 | 167.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
5.1 | 25.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
5.0 | 30.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
5.0 | 496.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
5.0 | 50.1 | GO:0015643 | toxic substance binding(GO:0015643) |
5.0 | 49.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
5.0 | 14.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
4.9 | 29.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
4.9 | 39.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
4.9 | 14.8 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
4.9 | 63.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.9 | 14.7 | GO:0071253 | connexin binding(GO:0071253) |
4.9 | 34.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
4.9 | 24.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
4.9 | 14.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
4.8 | 4.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
4.8 | 38.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
4.8 | 67.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
4.8 | 224.8 | GO:0017022 | myosin binding(GO:0017022) |
4.7 | 99.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
4.7 | 19.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
4.7 | 42.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
4.7 | 23.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
4.7 | 18.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
4.6 | 13.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
4.6 | 60.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
4.6 | 13.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
4.6 | 13.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
4.6 | 32.1 | GO:0033691 | sialic acid binding(GO:0033691) |
4.6 | 59.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
4.6 | 96.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
4.6 | 18.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
4.6 | 27.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
4.5 | 22.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
4.5 | 9.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
4.5 | 13.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.4 | 35.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
4.4 | 13.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
4.4 | 53.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
4.4 | 39.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
4.4 | 78.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
4.4 | 105.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
4.4 | 113.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
4.4 | 17.4 | GO:0046790 | virion binding(GO:0046790) |
4.3 | 21.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
4.3 | 39.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
4.3 | 203.5 | GO:0044325 | ion channel binding(GO:0044325) |
4.3 | 17.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
4.3 | 17.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
4.3 | 17.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
4.3 | 17.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
4.2 | 8.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
4.2 | 337.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
4.1 | 4.1 | GO:0051870 | methotrexate binding(GO:0051870) |
4.1 | 12.4 | GO:0097001 | ceramide binding(GO:0097001) |
4.1 | 16.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
4.1 | 4.1 | GO:2001070 | starch binding(GO:2001070) |
4.1 | 73.5 | GO:0042805 | actinin binding(GO:0042805) |
4.1 | 32.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
4.0 | 60.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
4.0 | 4.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
3.9 | 3.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
3.9 | 15.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
3.9 | 27.2 | GO:0001968 | fibronectin binding(GO:0001968) |
3.9 | 7.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
3.9 | 66.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
3.8 | 7.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.8 | 3.8 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
3.8 | 11.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
3.8 | 3.8 | GO:0051378 | serotonin binding(GO:0051378) |
3.8 | 72.4 | GO:0030332 | cyclin binding(GO:0030332) |
3.8 | 15.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
3.8 | 45.6 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
3.8 | 15.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
3.8 | 3.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
3.7 | 26.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
3.7 | 11.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
3.7 | 18.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
3.7 | 11.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
3.7 | 44.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
3.6 | 10.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
3.6 | 10.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
3.6 | 3.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
3.6 | 21.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
3.6 | 78.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
3.6 | 7.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
3.5 | 14.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
3.5 | 10.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.5 | 45.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
3.5 | 17.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
3.5 | 10.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
3.4 | 13.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
3.4 | 6.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
3.4 | 6.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
3.4 | 10.2 | GO:0030957 | Tat protein binding(GO:0030957) |
3.4 | 13.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
3.4 | 13.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
3.4 | 3.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
3.3 | 46.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
3.3 | 33.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
3.3 | 13.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
3.3 | 19.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
3.3 | 13.1 | GO:0035198 | miRNA binding(GO:0035198) |
3.3 | 78.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
3.3 | 61.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
3.2 | 9.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
3.2 | 41.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
3.2 | 12.7 | GO:0043495 | protein anchor(GO:0043495) |
3.2 | 31.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
3.1 | 44.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
3.1 | 84.5 | GO:0019894 | kinesin binding(GO:0019894) |
3.1 | 18.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.1 | 9.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
3.1 | 6.2 | GO:2001069 | glycogen binding(GO:2001069) |
3.1 | 73.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
3.0 | 48.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
3.0 | 27.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
3.0 | 233.3 | GO:0008201 | heparin binding(GO:0008201) |
3.0 | 48.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.0 | 33.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
3.0 | 9.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
3.0 | 12.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
3.0 | 9.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
3.0 | 11.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
3.0 | 637.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
3.0 | 8.9 | GO:0016151 | nickel cation binding(GO:0016151) |
3.0 | 8.9 | GO:0032052 | bile acid binding(GO:0032052) |
2.9 | 50.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
2.9 | 17.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
2.9 | 17.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
2.9 | 11.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
2.9 | 25.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.9 | 46.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
2.9 | 8.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.9 | 25.7 | GO:0043274 | phospholipase binding(GO:0043274) |
2.8 | 711.6 | GO:0003779 | actin binding(GO:0003779) |
2.8 | 2.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
2.8 | 967.3 | GO:0005509 | calcium ion binding(GO:0005509) |
2.7 | 5.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
2.7 | 8.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.7 | 2.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
2.7 | 21.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
2.6 | 13.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
2.6 | 54.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
2.6 | 10.3 | GO:0030507 | spectrin binding(GO:0030507) |
2.6 | 7.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.6 | 17.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
2.6 | 25.6 | GO:0044653 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
2.5 | 129.8 | GO:0019955 | cytokine binding(GO:0019955) |
2.5 | 81.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
2.5 | 5.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.5 | 7.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.5 | 5.0 | GO:0043199 | sulfate binding(GO:0043199) |
2.5 | 5.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.5 | 27.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
2.5 | 12.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.5 | 22.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.5 | 7.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.5 | 27.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
2.5 | 7.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.4 | 7.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
2.4 | 2.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
2.4 | 36.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
2.4 | 52.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
2.4 | 16.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.4 | 21.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
2.4 | 26.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
2.3 | 23.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
2.3 | 42.1 | GO:0050699 | WW domain binding(GO:0050699) |
2.3 | 9.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.3 | 11.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
2.2 | 4.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
2.2 | 39.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
2.2 | 15.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.2 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.2 | 6.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
2.1 | 10.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.1 | 2.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.1 | 6.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.1 | 4.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.1 | 39.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
2.1 | 6.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.0 | 355.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
2.0 | 7.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.0 | 80.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.9 | 25.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.9 | 21.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
1.9 | 11.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.9 | 3.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.9 | 30.7 | GO:0005537 | mannose binding(GO:0005537) |
1.9 | 9.6 | GO:0030371 | translation repressor activity(GO:0030371) |
1.9 | 1.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.9 | 9.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.9 | 9.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.9 | 13.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
1.8 | 9.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.8 | 10.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.8 | 18.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.8 | 10.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.7 | 14.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.7 | 5.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.7 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.7 | 3.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.7 | 6.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.7 | 3.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.7 | 3.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.7 | 6.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.7 | 3.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.7 | 51.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.7 | 10.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.6 | 4.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.6 | 37.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.6 | 4.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.6 | 8.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.6 | 113.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
1.6 | 4.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.6 | 3.1 | GO:0070840 | dynein complex binding(GO:0070840) |
1.5 | 16.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
1.5 | 12.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.5 | 6.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.5 | 6.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.5 | 6.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.5 | 4.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.5 | 1.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.4 | 7.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.4 | 4.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.4 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.4 | 4.1 | GO:0019862 | IgA binding(GO:0019862) |
1.4 | 4.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.3 | 18.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.3 | 4.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.3 | 9.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.3 | 14.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.3 | 3.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.3 | 11.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 11.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.3 | 3.8 | GO:0004096 | catalase activity(GO:0004096) |
1.3 | 3.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.2 | 7.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.2 | 1.2 | GO:0032564 | dATP binding(GO:0032564) |
1.2 | 4.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.2 | 9.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.2 | 3.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.2 | 3.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.2 | 2.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
1.2 | 3.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 14.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.1 | 6.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.1 | 1.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
1.1 | 18.8 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
1.1 | 3.3 | GO:0002046 | opsin binding(GO:0002046) |
1.1 | 3.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 13.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.0 | 453.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
1.0 | 5.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
1.0 | 4.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.0 | 8.0 | GO:0032183 | SUMO binding(GO:0032183) |
1.0 | 13.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.0 | 3.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.0 | 11.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.0 | 5.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.0 | 6.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.0 | 4.8 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.0 | 2.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.9 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 2.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.9 | 12.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.9 | 40.6 | GO:0060090 | binding, bridging(GO:0060090) |
0.9 | 4.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.9 | 10.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.9 | 38.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.9 | 2.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 25.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 16.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.8 | 1.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.8 | 4.2 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.8 | 2.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.8 | 3.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.8 | 4.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.8 | 3.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 11.1 | GO:0003774 | motor activity(GO:0003774) |
0.7 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 2.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.7 | 3.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.7 | 2.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.7 | 1.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 7.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 7.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.6 | 3.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 1.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 5.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.6 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 6.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 11.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.6 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 1.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 7.1 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.5 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 1.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 12.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.5 | 8.9 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.5 | 34.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.5 | 3.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 1.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.4 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 9.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 6.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 2.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.4 | 14.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.4 | 4.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.4 | 1.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 2.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 1.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 1.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 5.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 7.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 9.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 20.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 10.3 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 4.5 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 4.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 8.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 34.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.4 | 523.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
15.6 | 15.6 | PID IGF1 PATHWAY | IGF1 pathway |
14.1 | 14.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
13.1 | 196.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
12.6 | 164.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
11.9 | 71.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
10.4 | 93.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
9.0 | 108.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
8.9 | 196.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
8.9 | 303.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
8.9 | 302.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
8.7 | 155.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
8.7 | 95.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
7.6 | 53.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
7.5 | 193.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
6.8 | 163.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
6.4 | 167.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
6.3 | 138.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
6.2 | 61.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
6.2 | 228.3 | PID SHP2 PATHWAY | SHP2 signaling |
6.2 | 265.1 | NABA COLLAGENS | Genes encoding collagen proteins |
6.1 | 79.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
6.1 | 55.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
6.1 | 103.0 | PID REELIN PATHWAY | Reelin signaling pathway |
6.0 | 120.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
5.9 | 940.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
5.9 | 134.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
5.8 | 11.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
5.7 | 22.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
5.6 | 44.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
5.2 | 99.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
5.0 | 39.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
4.8 | 163.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
4.7 | 61.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
4.7 | 14.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
4.7 | 28.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
4.6 | 41.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
4.6 | 13.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
4.5 | 163.3 | PID BMP PATHWAY | BMP receptor signaling |
4.4 | 48.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
4.3 | 21.4 | PID ALK2 PATHWAY | ALK2 signaling events |
4.3 | 12.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
4.1 | 33.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
4.1 | 16.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
4.1 | 78.1 | PID RAS PATHWAY | Regulation of Ras family activation |
4.0 | 544.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
3.9 | 11.7 | PID EPO PATHWAY | EPO signaling pathway |
3.9 | 97.4 | PID FGF PATHWAY | FGF signaling pathway |
3.8 | 30.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
3.7 | 91.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
3.6 | 21.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.5 | 134.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
3.5 | 28.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
3.5 | 24.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
3.5 | 813.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
3.4 | 10.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
3.4 | 24.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.3 | 10.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
3.2 | 41.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
3.0 | 53.2 | PID ARF 3PATHWAY | Arf1 pathway |
2.9 | 171.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
2.8 | 97.4 | PID NOTCH PATHWAY | Notch signaling pathway |
2.7 | 43.4 | PID INSULIN PATHWAY | Insulin Pathway |
2.7 | 8.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.5 | 54.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
2.4 | 489.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
2.4 | 21.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
2.4 | 16.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
2.4 | 2.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.4 | 2.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.3 | 23.3 | PID ARF6 PATHWAY | Arf6 signaling events |
2.3 | 25.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.2 | 19.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
2.1 | 60.3 | PID LKB1 PATHWAY | LKB1 signaling events |
2.0 | 31.5 | PID CDC42 PATHWAY | CDC42 signaling events |
2.0 | 21.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.9 | 28.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.8 | 10.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.8 | 17.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.6 | 26.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.4 | 7.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.4 | 31.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.3 | 12.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.3 | 5.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.1 | 13.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.1 | 7.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.0 | 18.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.0 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 13.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.9 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.9 | 15.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.8 | 5.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 3.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.8 | 4.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 4.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 7.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 11.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.7 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 15.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 5.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 6.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 3.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 4.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.1 | 361.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
24.9 | 373.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
23.5 | 329.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
23.3 | 116.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
21.0 | 293.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
20.6 | 884.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
20.4 | 346.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
19.4 | 77.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
17.7 | 159.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
17.3 | 449.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
17.2 | 51.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
16.3 | 32.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
16.2 | 129.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
16.1 | 177.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
16.0 | 176.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
15.5 | 155.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
14.2 | 555.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
13.9 | 320.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
13.8 | 27.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
13.5 | 309.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
12.4 | 136.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
12.2 | 279.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
12.0 | 228.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
11.5 | 11.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
10.5 | 136.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
9.5 | 123.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
9.5 | 9.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
9.3 | 120.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
9.3 | 18.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
9.3 | 120.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
9.2 | 101.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
8.8 | 35.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
8.8 | 157.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
8.6 | 94.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
8.4 | 184.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
8.3 | 66.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
8.1 | 153.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
7.8 | 23.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
7.8 | 171.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
7.8 | 54.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
7.7 | 277.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
7.2 | 331.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
7.2 | 57.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
7.1 | 78.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
7.1 | 21.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
7.0 | 48.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
7.0 | 250.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
6.6 | 19.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
6.5 | 77.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
6.4 | 57.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
6.3 | 6.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
6.3 | 138.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
6.1 | 110.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
6.1 | 98.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
5.7 | 28.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
5.6 | 105.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
5.5 | 21.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
5.4 | 42.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
5.1 | 77.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
5.0 | 5.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
5.0 | 5.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
5.0 | 59.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
4.8 | 154.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
4.8 | 24.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
4.6 | 41.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
4.6 | 45.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
4.6 | 50.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
4.5 | 72.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
4.5 | 13.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
4.3 | 38.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
4.3 | 42.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
4.3 | 47.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
4.1 | 28.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
4.1 | 115.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
4.1 | 86.2 | REACTOME KINESINS | Genes involved in Kinesins |
4.1 | 262.2 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
4.1 | 20.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
4.0 | 100.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
3.9 | 19.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
3.9 | 66.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.8 | 11.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.8 | 11.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
3.7 | 3.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
3.7 | 25.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
3.7 | 235.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
3.5 | 10.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
3.5 | 91.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
3.5 | 97.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
3.4 | 75.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
3.4 | 20.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
3.4 | 47.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
3.2 | 57.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
3.2 | 28.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
3.1 | 49.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
3.0 | 36.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
2.9 | 11.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.9 | 22.9 | REACTOME OPSINS | Genes involved in Opsins |
2.8 | 11.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
2.7 | 21.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.5 | 17.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.5 | 43.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
2.5 | 70.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
2.5 | 17.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.4 | 34.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.4 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
2.4 | 21.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
2.4 | 4.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.3 | 16.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
2.3 | 11.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.1 | 26.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
2.0 | 18.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.9 | 29.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.9 | 28.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.9 | 20.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.9 | 3.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
1.8 | 14.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
1.7 | 8.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.7 | 153.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
1.6 | 31.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
1.5 | 19.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.4 | 1.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.4 | 84.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.3 | 58.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.2 | 5.9 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
1.2 | 22.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.2 | 75.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 4.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.0 | 11.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 10.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 3.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.9 | 86.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.9 | 43.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.9 | 8.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 9.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.8 | 8.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 9.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.6 | 6.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 6.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.6 | 13.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 8.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.5 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 1.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 6.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 2.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 1.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 2.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 1.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 10.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 4.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |